Sham Mailankody

I am a medical oncologist with the Myeloma Service and a member of the Cellular Therapeutics Center and the Center for Health Policy and Outcomes at Memorial Sloan Kettering Cancer Center. My research focuses on the clinical development of novel immune and cellular therapies for patients with multiple myeloma and translational research focused on better understanding the responses to cellular therapies and possible mechanisms of relapse. I am the principal investigator for multiple chimeric antigen receptor (CAR) T trials for multiple myeloma, including the first trials of an allogeneic CAR T cell therapy and autologous GPRC5D CAR T cells for myeloma .